欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SI/H/0311/001
药品名称Aptazol 40 mg powder for solution for injection
活性成分
    • Pantoprazole sodium sesquihydrate 40.0 mg
剂型Powder for solution for injection
上市许可持有人APTA MEDICA INTERNACIONAL druzba za trzenje farmacevtskih izdelkov in medicinskih pripomockov d.o.o. Likozarjeva Ulica 6 1000 Ljubljana Slovenia
参考成员国 - 产品名称Slovenia (SI)
Aptazol 40 mg prašek za raztopino za injiciranje
互认成员国 - 产品名称
    • Malta (MT)
      Aptazol 40 mg powder for solution for injection
    • Croatia (HR)
    • Austria (AT)
    • Poland (PL)
      Pantoprazole Apharma
    • Hungary (HU)
    • Bulgaria (BG)
      Aptazol 40 mg powder for solution for injection
    • Cyprus (CY)
      Aptazol 40 mg powder for solution for injection
    • Czechia (CZ)
      Aptazol
    • Romania (RO)
    • Slovakia (SK)
许可日期2025/02/19
最近更新日期2025/02/19
药物ATC编码
    • A02BC02 pantoprazole
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase